A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Société Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)
- Author
- VASSAL, Gilles1 ; GIAMMARILE, Francesco2 ; PICHON, Fabienne7 ; RUBIE, Hervé8 ; CISAR, Laura9 ; ASSADOURIAN, Syluie10 ; MORLAND, Bruce11 ; BROOKS, Mariel3 ; GEOERGER, Birgit1 ; COUANET, Dominique1 ; MICHON, Jean4 ; STOCKDALE, Elizabeth3 ; SCHELL, Matthias2 ; GEOFFRAY, Anne5 ; GENTET, Jean-Claude6
[1] Department of Paediatrics, Institute Gustaue Roussy, 39, Rue Camille Desmoulins, 94805 -Villejuif, France
[2] Nuclear Medicine Unit, Centre Leon Bérard, 28, Rue Laennec, 69373-Lyon, France
[3] Royal Aberdeen Children's Hospital, Westburn Road, Foresterhill, AB25 2ZG-Aberdeen, United Kingdom
[4] Department of Paediatrics, Institute Curie, 26 Rue d'Ulm, 75248-Paris, France
[5] children's Hospital Lenval, Nice, Parc de l'Enchanteresse 13, Avenue Ste Colette, 06100-Nice, France
[6] Department of Paediatrics, La Timone Hospital, Boulevard Jean Moulin, 13385-Marseille, France
[7] Department of Paediatrics, Oscar Lambret Center, 3, Rue, Combemale 59020-Lille, France
[8] Purpan Hospital, Place du Docteur Baylac, 31059-Toulouse, France
[9] Pjizer Inc, 235 E 42nd Street, New York, NY-10017, United States
[10] sanofi-Aventis, 20, Avenue Raymond Aron, 92165-Antony, France
[11] Birmingham Children's Hospital NHS Trust, Steelhouse Lane, B4 6NH-Birmingham, United Kingdom - Source
European journal of cancer (1990). 2008, Vol 44, Num 16, pp 2453-2460, 8 p ; ref : 33 ref
- ISSN
- 0959-8049
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- Elsevier, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Irinotecan Neuroblastoma Paediatrics Phase II
- Keyword (fr)
- Anticancéreux Cancer Cancérologie Coopération Enfant Essai clinique phase II Irinotécan Neuroblastome Récidive Résistance traitement Traitement Tumeur maligne Europe Royaume-Uni Camptothécine dérivé DNA topoisomerase Enzyme Homme Inhibiteur de la topoisomérase I Inhibiteur enzyme Isomerases Pathologie du système nerveux sympathique Pathologie du système nerveux
- Keyword (en)
- Antineoplastic agent Cancer Cancerology Cooperation Child Phase II trial Irinotecan Neuroblastoma Relapse Treatment resistance Treatment Malignant tumor Europe United Kingdom Camptothecin derivatives DNA topoisomerase Enzyme Human Topoisomerase I inhibitor Enzyme inhibitor Isomerases Autonomic neuropathy Nervous system diseases
- Keyword (es)
- Anticanceroso Cáncer Cancerología Cooperación Niño Ensayo clínico fase II Irinotecán Neuroblastoma Recaida Resistencia tratamiento Tratamiento Tumor maligno Europa Reino Unido Camptothecin derivado DNA topoisomerase Enzima Hombre Inhibidor topoisomerase I Inhibidor enzima Isomerases Sistema nervioso simpático patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20852914
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ejca.2008.08.003 
https://dx.doi.org/10.1016/j.ejca.2008.08.003
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2008.08.003\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2453\";s:8:\"\u0000*\u0000epage\";s:4:\"2460\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VASSAL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Gilles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:21:\"GIAMMARILE, Francesco\";i:1;s:16:\"PICHON, Fabienne\";i:2;s:13:\"RUBIE, Herv\u00e9\";i:3;s:12:\"CISAR, Laura\";i:4;s:19:\"ASSADOURIAN, Syluie\";i:5;s:14:\"MORLAND, Bruce\";i:6;s:14:\"BROOKS, Mariel\";i:7;s:16:\"GEOERGER, Birgit\";i:8;s:18:\"COUANET, Dominique\";i:9;s:12:\"MICHON, Jean\";i:10;s:20:\"STOCKDALE, Elizabeth\";i:11;s:16:\"SCHELL, Matthias\";i:12;s:14:\"GEOFFRAY, Anne\";i:13;s:19:\"GENTET, Jean-Claude\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2008.08.003\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2453\";s:8:\"\u0000*\u0000epage\";s:4:\"2460\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VASSAL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Gilles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:21:\"GIAMMARILE, Francesco\";i:1;s:16:\"PICHON, Fabienne\";i:2;s:13:\"RUBIE, Herv\u00e9\";i:3;s:12:\"CISAR, Laura\";i:4;s:19:\"ASSADOURIAN, Syluie\";i:5;s:14:\"MORLAND, Bruce\";i:6;s:14:\"BROOKS, Mariel\";i:7;s:16:\"GEOERGER, Birgit\";i:8;s:18:\"COUANET, Dominique\";i:9;s:12:\"MICHON, Jean\";i:10;s:20:\"STOCKDALE, Elizabeth\";i:11;s:16:\"SCHELL, Matthias\";i:12;s:14:\"GEOFFRAY, Anne\";i:13;s:19:\"GENTET, Jean-Claude\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2008.08.003\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2008.08.003\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2453\";s:8:\"\u0000*\u0000epage\";s:4:\"2460\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VASSAL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Gilles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:21:\"GIAMMARILE, Francesco\";i:1;s:16:\"PICHON, Fabienne\";i:2;s:13:\"RUBIE, Herv\u00e9\";i:3;s:12:\"CISAR, Laura\";i:4;s:19:\"ASSADOURIAN, Syluie\";i:5;s:14:\"MORLAND, Bruce\";i:6;s:14:\"BROOKS, Mariel\";i:7;s:16:\"GEOERGER, Birgit\";i:8;s:18:\"COUANET, Dominique\";i:9;s:12:\"MICHON, Jean\";i:10;s:20:\"STOCKDALE, Elizabeth\";i:11;s:16:\"SCHELL, Matthias\";i:12;s:14:\"GEOFFRAY, Anne\";i:13;s:19:\"GENTET, Jean-Claude\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2008.08.003\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2453\";s:8:\"\u0000*\u0000epage\";s:4:\"2460\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VASSAL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Gilles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:21:\"GIAMMARILE, Francesco\";i:1;s:16:\"PICHON, Fabienne\";i:2;s:13:\"RUBIE, Herv\u00e9\";i:3;s:12:\"CISAR, Laura\";i:4;s:19:\"ASSADOURIAN, Syluie\";i:5;s:14:\"MORLAND, Bruce\";i:6;s:14:\"BROOKS, Mariel\";i:7;s:16:\"GEOERGER, Birgit\";i:8;s:18:\"COUANET, Dominique\";i:9;s:12:\"MICHON, Jean\";i:10;s:20:\"STOCKDALE, Elizabeth\";i:11;s:16:\"SCHELL, Matthias\";i:12;s:14:\"GEOFFRAY, Anne\";i:13;s:19:\"GENTET, Jean-Claude\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.ejca.2008.08.003\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:9:\"\u0000*\u0000jtitle\";s:33:\"European journal of cancer (1990)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Eur. j. cancer (1990)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"44\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2453\";s:8:\"\u0000*\u0000epage\";s:4:\"2460\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-8049\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VASSAL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Gilles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:21:\"GIAMMARILE, Francesco\";i:1;s:16:\"PICHON, Fabienne\";i:2;s:13:\"RUBIE, Herv\u00e9\";i:3;s:12:\"CISAR, Laura\";i:4;s:19:\"ASSADOURIAN, Syluie\";i:5;s:14:\"MORLAND, Bruce\";i:6;s:14:\"BROOKS, Mariel\";i:7;s:16:\"GEOERGER, Birgit\";i:8;s:18:\"COUANET, Dominique\";i:9;s:12:\"MICHON, Jean\";i:10;s:20:\"STOCKDALE, Elizabeth\";i:11;s:16:\"SCHELL, Matthias\";i:12;s:14:\"GEOFFRAY, Anne\";i:13;s:19:\"GENTET, Jean-Claude\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:227:\"A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Soci\u00e9t\u00e9 Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
